Illumina to Seek FDA OK for MDx System This Year

Illumina CEO Jay Flatley said today that the company hopes to receive FDA clearance of its BeadXpress system in the second half of 2009.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.